FILTER
FILTERED INTERVIEW RESULTS
Kris Jedrzejczyk
MANAGING DIRECTOR, BLU ROCK MINING SERVICES
"The signs indicate a promising trend for exploration, particularly in copper, cobalt, and lithium, especially in Zambia."
Pierre Léveillé
PRESIDENT AND CEO, KORYX COPPER INC
"We have a highly experienced team ready to make discoveries in Zambia and to develop our exciting Haib Copper project in Namibia."
Mark Bristow
PRESIDENT & CEO, BARRICK GOLD
"Our successful exploration programs are feeding high-quality prospects into an already bulging pipeline and we expect to grow our reserves net of depletion again this year."
Pierre Léveillé
PRESIDENT & CEO, DEEP SOUTH RESOURCES
Deep South Resources remains determined to mine its Haib copper project in Namibia.
Shahram Tafazoli
FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Bernard Kaninda
AFRICA REGIONAL DIRECTOR, MAXAM
Maxam offers sophisticated blasting technology that considers all aspects of the conditions, as well as the environment that surrounds them in West Africa.
Stephen Smithyman
CEO, KANU EQUIPMENT
Kanu Equipment comments on the challenges and opportunities in Africa for a mining and construction dealership.
John Gladston
GOVERNMENT AFFAIRS MANAGER, FIRST QUANTUM MINERALS LIMITED (FIRST QUANTUM)
First Quantum comments on the performance of its Zambian copper assets during 2020.
Olivier Terra
MANAGING DIRECTOR, BOLLORÉ TRANSPORT & LOGISTICS ZAMBIA
Bolloré Zambia comment on the logistics issues that they deal with in landlocked Zambia.
Raphael Khalifa
FOUNDER, TEMBO POWER
Tembo Power is developing hydropower projects across Africa with a focus on DRC.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
